Literature DB >> 19133866

Feasibility and logistics of MRI before thrombolytic treatment.

C Sølling1, M Ashkanian, N Hjort, C Gyldensted, G Andersen, L Østergaard.   

Abstract

OBJECTIVES: The study analyzes feasibility and time-delays in Magnetic resonance imaging (MRI) based thrombolysis and estimate the impact of MRI on individual tissue plasminogen activator (rtPA) treatment.
MATERIALS AND METHODS: Feasibility of MRI and time logistics were prospectively recorded in patients referred with presumed acute stroke over a 2 year time period. Door-to-needle-times (DNT) were compared with those of patients treated with rtPA after conventional CT during the same time period, and to published open label studies.
RESULTS: We received 174 patients with presumed stroke. MRI was feasible in 141 of 161 (88%) of those requiring acute imaging. MRI supported the decision to treat 11 patients with mild symptoms or seizures, and not to treat four patients with extensive infarctions. Median 'door-to-needle time' (DNT) in MR scanned patients (70 min), did not differ significantly from DNT after conventional CT (n = 17, DNT = 66 min, P = 0.27) or the Safe Implementation of Thrombolysis in Stroke (SITS-MOST) registry (DNT = 68 min).
CONCLUSIONS: Magnetic resonance imaging can be performed in the majority of acute stroke patients without delaying treatment. MRI may affect decision making in a large proportion of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19133866     DOI: 10.1111/j.1600-0404.2008.01136.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Delays in the timely diagnosis of stroke in children.

Authors:  Gabrielle A deVeber
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

2.  Screening with MRI for Accurate and Rapid Stroke Treatment: SMART.

Authors:  Shreyansh Shah; Marie Luby; Karen Poole; Teresa Morella; Elizabeth Keller; Richard T Benson; John K Lynch; Zurab Nadareishvili; Amie W Hsia
Journal:  Neurology       Date:  2015-05-13       Impact factor: 9.910

Review 3.  Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review.

Authors:  Albert J Yoo; Benjamin Pulli; R Gilberto Gonzalez
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-07

4.  Thrombolysis in acute ischaemic stroke: an update.

Authors:  Thompson Robinson; Zahid Zaheer; Amit K Mistri
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

5.  MRI before intraarterial therapy in ischemic stroke: feasibility, impact, and safety.

Authors:  Claus Z Simonsen; Leif H Sørensen; Sanja Karabegovic; Irene K Mikkelsen; Marie L Schmitz; Niels Juul; Albert J Yoo; Grethe Andersen
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-02       Impact factor: 6.200

6.  Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands.

Authors:  Anna Miquel-Cases; Lotte M G Steuten; Lisanne S Rigter; Wim H van Harten
Journal:  BMC Cancer       Date:  2016-09-05       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.